Table 2.

Additional CT findings, clinical and laboratory findings, and treatment outcomes of the three morphological types of amebic liver abscesses

Variables	Type I (n = 74)	Type II (n = 31)	Type III (n = 7)	p-value
Additional CT findings
Size of abscess (cm)	10.1 ± 2.5	8.6 ± 1.4	9.7 ± 1.9	0.010
Number of abscesses	2.4 ± 2.4	1.4 ± 0.9	1.1 ± 0.4	0.039
Intracavitary hemorrhage	4 (5%)	1(3%)	0	0.744
Intrahepatic ductal dilations	2 (3%)	0	0	0.593
Intracavitary air	3 (4%)	0	0	0.453
Rupture	42 (57%)	2 (6%)	0	< 0.001
Ascites	23 (31%)	2 (6%)	0	0.007
Colonic manifestations	28 (38%)	4 (13%)	0	0.008
Pleural effusion	42 (57%)	4 (13%)	0	< 0.001
Clinical findings
Age (years)	44.5 ± 13.4	41.1 ± 9.1	39.1 ± 5.6	0.277
Duration of symptoms (days)	10.5 ± 4.4	27.6 ± 6.5	41.5 ± 5.2	< 0.001
Abdominal pain	74 (100%)	31 (100%)	7 (100%)
Fever	62 (83%)	12 (39%)	0	< 0.001
Laboratory findings
TLC (/μL)	24,996 ± 9,743	12,620 ± 4,826	8,325 ± 2,637	< 0.001
Total bilirubin (mg/dL)	2.4 ± 1.2	1.17 ± 0.59	0.54 ± 0.22	< 0.001
Serum albumin (g/dL)	1.96 ± 0.48	2.74 ± 0.56	2.43 ± 0.37	< 0.001
AST (U/L)	153.1 ± 125.6	54.6 ± 28.4	37.1 ± 18.4	< 0.001
ALT (U/L)	123.7 ± 118.9	52.9 ± 21.1	31.4 ± 5.2	0.004
ALP(U/L)	343.6 ± 146.01	296.3 ± 110.7	254.7 ± 59.5	0.554
Treatment and outcomes
Inpatient hospital admission	67 (90.5%)	11 (35.5%)	1 (14.3%)	< 0.001
Intensive care unit admission	15 (20.3%)	0	0	< 0.012
Length of hospital stay (days)	10.7 ± 3.44	6.1 ± 1.9	3	< 0.001
Drug alone	14 (19%)	15(48%)	0	0.002
Drainage	60 (81%)	16 (52%)	7 (100%)	0.002
Surgery	1 (1%)	0	0	0.772
Mortality	2 (3%)	0	0	0.593

P values in bold indicate statistically significant difference

Data are presented as n (%) or mean ± standard deviation

TLC total leukocyte counts, ALT alanine aminotransferase, AST aspartate aminotransferase, ALP alkaline phosphatase